SR

Subramani Rajendran

Active Director Director DIN 10229757
DIN 10229757 First appointment Jul 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Subramani Rajendran

Data last updated:

Subramani Rajendran is a Director at Intsia Pharma Private Limited (since 2023). The company operates in Trading. Intsia Pharma Private Limited reported revenue of ₹59.4 Lakh (FY 2024).

DIN 10229757
Primary Designation Director
Industry Trading
First Appointment 07 Jul 2023
Oldest Company Age 6 yrs
Largest company Intsia Pharma Private Limited · ₹59.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Intsia Pharma Private Limited U51909TN2020PTC137708
Director07 Jul 20232020₹59.4 Lakh (FY 2024)Active

Board colleagues of Subramani Rajendran

NameDINCompanyDesignation
Rajendran Kamesh08865221Intsia Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Intsia Pharma Private Limited
Premium access

Shareholding and investment profile for Subramani Rajendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subramani Rajendran

Subramani Rajendran currently holds 1 directorship: Intsia Pharma Private Limited (Director, since 07 Jul 2023, revenue ₹59.4 Lakh (FY 2024)).

Subramani Rajendran was first appointed on 07 Jul 2023 as Director at Intsia Pharma Private Limited.

The current boards of Subramani Rajendran's companies include Rajendran Kamesh (Intsia Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available